RATIONAL LABORATORY DIAGNOSTIC AND POSSIBILITIES OF INADEQUATE ANALYSES APPLICATION - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

RATIONAL LABORATORY DIAGNOSTIC AND POSSIBILITIES OF INADEQUATE ANALYSES APPLICATION

Description:

RATIONAL LABORATORY DIAGNOSTIC AND POSSIBILITIES OF INADEQUATE ANALYSES ... Big and unjustified demand. not for specific parameters. for 'all and everything' ... – PowerPoint PPT presentation

Number of Views:38
Avg rating:3.0/5.0
Slides: 29
Provided by: Dan681
Category:

less

Transcript and Presenter's Notes

Title: RATIONAL LABORATORY DIAGNOSTIC AND POSSIBILITIES OF INADEQUATE ANALYSES APPLICATION


1
RATIONAL LABORATORY DIAGNOSTIC AND POSSIBILITIES
OF INADEQUATE ANALYSES APPLICATION
  • Danica Popovic
  • Clinical Center of Montenegro

2
To improve the health
Laboratory diagnostic
3
  • 60 information
  • ? doctors use to set the diagnoses
  • information obtained in
  • laboratories
  • Lot of researches ? aim to improve the
    diagnostic system
  • ? to find the
    possibility for
  • more complex analyses

4
Improvement of laboratory diagnostic
  • Standardization of laboratory procedure
  • Simplification of laboratory procedure
  • Reduction of time necessary for analyses
  • Application of computer sample processing
  • The aim ? both to reduce the possibility of
    errors caused by human factor
  • ? protect the staff during the work

5
  • Big demands can be justified only
  • To receive patients with special pathology
  • When where are special protocols in treatment
  • In periodical controls of patients in some
    chronic program

6
  • Big and unjustified demand
  • ? not for specific
    parameters
  • ? for all and everything
  • Less clear situation ? this way can HELP
  • Insufficient education and experience
  • "Not to miss something
  • More experience and knowledge ? less analyses,
    specific analyses ? useful information

7
  • When you ask for analysis there should be clearly
    defined question and the analysis should give
    you the answer.
  • Infection bacterial or viral? ? ESR, WBC,
    differential count, or more specific C reactive
    proteins, or more specific procalcitonin
    (screening diagnostic)

8
Conclusion
  • method
  • Induction Deduction
  • to make more analyses which help to confirm or to
    exclude certain opinions

9
  • Tumor markers compounds that make and excrete
    tumor cells in more guantity than normal cells
  • Tumor marker is any compound whose
    concentration can be increased in the presence of
    malignant disease
  • ESR and the activity of LDH are the classical
    tumor markers. These markers are also increased
    in inflammation and necrosis process, and that is
    why they are highly nonspecific for malignancy

10
  • Tumor markers are macromolecules and their
    concentration is related to the presence and
    diffusion of malignant tumor
  • Tumor markers are very important to follow the
    treatment efficiency, as well to predict the
    response to the therapy

11
Application is limited
  • in the field of screening
  • in the diagnostics of localization and stage
  • tracking and prognoses of malignamcy

12
Ideal tumor marker
  • specific for tested tumor (malignant process)
  • correlation with tumor mass
  • level in tested sample is increased in presence
    of metastases (in the stage when physician nor
    methods currently available can not detect their
    presence)
  • if it is present in plasma of healthy person its
    concentration is lower than in certain stage of
    cancer
  • indicate the terapy effect
  • concentration is in accordance with prognosis
    state
  • metods for their determination in body fluids are
    simple and not expensive

13
  • Criteria for ideal tumor marker, which would have
    sensitivity and specificity 100 have not been
    fulfilled by any known tumor marker
  • Use can be helpful to diagnose the cancer but it
    can not to be the only criteria

14
  • Problem sensitivity and specificity ? connected
    with chosen upper limits of referential range
  • Lower cut-off value ? higher sensitivity, lower
    specificity
  • High cut-off value ? higher specificity, lower
    sensitivity

15
Estimation the value of tumor marker
  • population of healthy people
  • patients with benign disease
  • patients with different types of cancer
  • Example There should be taken patients with
    hronic gastritis when we define referential
    values of tumor markers for stomach cancer

16
  • Examination patients with specific cancer ? the
    various stages of cancer should be included
  • Tumor markers are used to follow the therapy ?
    the set of samples should be taken to estimate
    the efficiency of tumor markers
  • To value markers ? it is necessary to determine
    referential values, to calculate predictive
    values, distribution of marker's values and
    significance in disease estimation

17
  • This discovery leads
  • to better results in patient tracking after
    radical surgery
  • adequate treatment or
  • better results of illness

18
  • Tumor markerS with few exceptions are not
    adequate for primary diagnosis of malignancy.
    They do not show enough sensitivity and specifity
    for their purpose. False positive results in
    cancer diagnosis can lead to lot of psycho trauma
    while false negative results postpone the terapy,
    which can be fatal.
  • For various kinds of cancer, tumor markers are
    use as choice of first, that is second order. The
    combination of markers may increase diagnostic
    sensitivity
  • Insufficient specificity of a tumor marker,
    sometimes exclude its use in detection of tumor
    location, while sometimes it can be useful
  • For the state and prognosis, persistently
    extremly high concentration indicates the
    progress of illness and bad prognosis. There are
    significant individual variations in value level,
    so the values in the referential range do not
    exclude for sure the malignancy

19
Tumor markers that are frequently used in routine
work
  • Onkofetal proteins
  • Carcinoembryonic antigen (CEA)
  • Alpha-fetoprotein (AFP)
  • Human chorionic gonadotropin (hCG)
  • Carbohydrate antigen
  • CA-125
  • CA-19-9
  • CA-15-3 and CA 27-29
  • CA- 72-4
  • Enzymes
  • Creatin kinasa
  • Lactat dehidrogenasa
  • Prostata acid phosphatase
  • Prostate specific antigen (PSA)
  • Neuron-specific enolasa (NSE)
  • Amylase

20
  • Hormones and hormone receptors
  • ACTH and other endocrine hormones
  • Brest estrogen and progesterone receptors
  • Proteins as tumor markers
  • ?2- microglobulin
  • C-peptid
  • Feritin
  • Tireoglobulin
  • Other markers
  • Cytokeratin-19 (CYFRA 21-1)
  • Tissue polypeptide-antigen (TPA)
  • Tissue polypeptide-specific (TPS) antigen
  • Squamous cell carcinoma (SCC) antigen

21
Most of the freqently used tumor markers
  • Substances which only tumors excrete in different
    body parts
  • Markers which both malign and benign tissues
    excrete (PSA)
  • Tumor markers whose effect we track trough
    receptors increase (HER-2/neu)

22
Origin and control of preanalitic variation
  • The affects of preanalycal factors (abide the
    standard procedure regarding the preparation of
    patients, taking and processing of the samples
    for analyses)
  • Affects to analytic factors (are reduced to the
    least possible rate by using the quality control)
  • Results of clinical biochemical determination
    are interpreted by comparing with the referential
    values, and so the conclusion is made by
    comparing method. In order to perform this
    process properly, referential values for each
    specific parameter are necessary to exist.

23
Cyclic biological variable
  • Cyclic variation ? changes in the concentration
    of the analyte in certain period of day, week,
    month
  • Circadial variation (occurs during the course of
    a single day)
  • melantoin
  • iron, acid phosphatase
  • most electrolite (Na, K, P) in urine
  • hormons of hypophysis

24
  • Intradian variation (over a period greater than 1
    day)
  • menstrual cycle ? ovary hormones, Ca, Mg,
    cholesterol, PTH, renin, aldosterone,
    antidiuretic hormone
  • Intraindividual variation
  • electrolite, proteins, alkaline phosphatase (5)
  • bilirubin, creatine kinase, tryglicerides, most
    steroid hormone (20)
  • creatinine in urine (10)
  • Seasonal changes in nutrition and climate
    variation
  • 1,25-dihidroxy-vitamin D
  • urinary oxalate
  • bone alkaline phosphatase

25
VariationS caused by patient's state
  • Physical activity
  • Food ingestion
  • Stress (of any kind)

26
VariationS that are result of sample collecting
  • The technique of blood collecting
  • The type of the sample (arterial blood, venous
    blood, capillary blood)
  • Use of preserving agents and anticoagulants
  • Inadequate identification of sample and patient
  • Sample collecting with infants (sample collecting
    for metabolic errors, gathering of capillary
    blood)
  • Variations during urin collecting (biological,
    time of collecting, stability of sample)

27
Errors that can occur after sample collecting
  • Transport of samples
  • Preparation of samples (centrifugation)
  • Sample storage

28
Conclusion
  • Inadequate preparation of patient for a certain
    analysis and disrespect of rules referring
    preparation and sample analyzing, can lead to
    drastic deviation of results from the real
    values. Thus obtained results of analyses can be
    badly interpreted or abused in several ways and
    for different purposes, whether by doctor who
    asked for them or by patient himself.
Write a Comment
User Comments (0)
About PowerShow.com